HealthEquity Inc (HQY)
Activity ratios
Short-term
Turnover ratios
| Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | 10.20 | 10.81 | 10.04 | 9.59 | 9.14 | 9.53 | 9.55 | 8.62 | 8.42 | 8.99 | 8.28 | 8.55 | 8.21 | 8.40 | 9.63 | 9.40 | 9.63 | 11.20 | 9.88 | 8.81 |
| Payables turnover | 58.76 | 70.19 | 63.45 | 35.98 | 52.58 | 53.38 | 57.13 | 53.49 | 51.35 | 47.04 | 45.41 | 51.75 | 24.88 | 121.49 | 134.25 | 63.23 | 371.50 | 77.29 | 45.90 | 61.99 |
| Working capital turnover | 3.75 | 3.38 | 2.90 | 3.26 | 2.18 | 2.42 | 2.77 | 3.16 | 3.24 | 3.55 | 4.09 | 4.56 | 3.62 | 1.08 | 1.06 | 1.04 | 2.74 | 2.94 | 3.03 | 4.12 |
HealthEquity Inc's activity ratios indicate how efficiently the company is managing its assets and operations.
1. Receivables Turnover: This ratio measures how many times the company collects its accounts receivable during a specific period. HealthEquity's receivables turnover has been relatively stable over the years, ranging from 8.21 to 10.81. A higher turnover ratio indicates that the company is collecting its receivables more quickly.
2. Payables Turnover: This ratio reflects how efficiently the company is managing its trade payables. HealthEquity's payables turnover fluctuated over the years, with values ranging from 24.88 to 371.50. A higher turnover ratio suggests that the company is paying its suppliers more rapidly.
3. Working Capital Turnover: This ratio evaluates how effectively HealthEquity is utilizing its working capital to generate revenue. The company's working capital turnover varied between 1.04 and 4.56. A higher turnover ratio indicates that HealthEquity is efficiently using its working capital to support its operations.
Overall, these activity ratios provide insights into HealthEquity Inc's operational efficiency and effectiveness in managing its resources to drive business performance.
Average number of days
| Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Days of sales outstanding (DSO) | days | 35.78 | 33.77 | 36.37 | 38.07 | 39.95 | 38.32 | 38.22 | 42.34 | 43.34 | 40.61 | 44.10 | 42.68 | 44.46 | 43.43 | 37.89 | 38.82 | 37.92 | 32.60 | 36.93 | 41.42 |
| Number of days of payables | days | 6.21 | 5.20 | 5.75 | 10.15 | 6.94 | 6.84 | 6.39 | 6.82 | 7.11 | 7.76 | 8.04 | 7.05 | 14.67 | 3.00 | 2.72 | 5.77 | 0.98 | 4.72 | 7.95 | 5.89 |
HealthEquity Inc's Days of Sales Outstanding (DSO) have shown some fluctuations over the years, ranging from a low of 32.60 days in October 2020 to a high of 44.46 days in January 2022. This indicates the average number of days it takes for the company to collect revenue after a sale. Generally, a lower DSO is preferable as it indicates a faster collection of receivables.
Additionally, the Number of Days of Payables for HealthEquity Inc has also varied over time, with the lowest being 0.98 days in January 2021 and the highest at 14.67 days in January 2022. This ratio represents how long it takes the company to pay its suppliers and is an important factor in managing cash flow and working capital.
The Days of Inventory on Hand (DOH) data is not available, which limits the analysis of the efficiency of inventory management by HealthEquity Inc. A lower DOH indicates that inventory is turning over quickly, which is generally positive for a company.
Overall, HealthEquity Inc should aim to keep their DSO low, manage payables effectively, and optimize inventory turnover to enhance operational efficiency and overall financial performance.
Long-term
| Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | 371.68 | 296.48 | 237.01 | 200.34 | 159.39 | 119.60 | 96.68 | 80.56 | 63.40 | 50.48 | 41.52 | 35.02 | 30.71 | 28.34 | 26.11 | 25.48 | 24.07 | 22.66 | 20.10 | 17.17 |
| Total asset turnover | 0.35 | 0.33 | 0.31 | 0.31 | 0.30 | 0.30 | 0.29 | 0.28 | 0.26 | 0.26 | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.22 | 0.26 | 0.27 | 0.26 | 0.24 |
HealthEquity Inc's fixed asset turnover has been steadily increasing over the past few years, indicating the company's efficiency in generating revenue from its fixed assets. The ratio has more than doubled from 17.17 in April 2020 to 371.68 in January 2025, reflecting significant improvement.
In contrast, the total asset turnover of HealthEquity Inc has shown some fluctuations but generally maintained a stable trend. The ratio ranged from 0.22 to 0.35 over the same period, indicating that the company is generating a moderate level of sales compared to its total assets.
Overall, the increasing trend in fixed asset turnover coupled with the relatively stable total asset turnover suggests that HealthEquity Inc is using its fixed assets effectively to generate sales, contributing to its overall operational efficiency and profitability.